Literature DB >> 5431658

Abnormal serum growth hormone response to exercise in juvenile diabetics.

A P Hansen.   

Abstract

Groups of male nonobese juvenile diabetics with recent onset, short term (1-8 yr), and long-term (12-30 yr) diabetes as well as comparable nondiabetic controls were studied during exercise experiments. The chosen exercise load, 450 kg/min for 20 min never induced changes in serum growth hormone in our nondiabetic control subjects. THE PRINCIPAL RESULTS OF THE STUDY WERE AS FOLLOWS: (a) an immediate high rise in serum growth hormone followed the commencement of exercise in all diabetics. The increase and pattern of serum growth hormone was not related to the duration of the diabetes. (b) The abnormal growth hormone response to exercise in diabetics was observed when the patients were in poor control as well as when they were in clinically excellent control (fasting blood glucose level between 100 and 140 mg/100 ml). (c) However, the abnormal serum growth hormone response was significantly diminished when exceedingly strict control was achieved (fasting blood glucose level between 60 and 100 mg/100 ml). In two of these experiments an entirely normal growth hormone pattern was obtained. (d) The change in serum growth hormone pattern during regulation was totally unrelated to the changes in serum free fatty acid patterns. A normal free fatty acid level and exercise pattern was obtained much earlier during the improved control. (e) Fasting serum growth hormone levels were also significantly raised in the juvenile diabetics irrespective of the diabetes duration. (f) Fasting serum growth hormone levels were also significantly decreased during regulation. Furthermore, a significant correlation between blood glucose and fasting serum growth hormone concentration was established. (g) In the juvenile diabetics a significant increase in serum insulin was observed at the point of time when exercise was concluded.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5431658      PMCID: PMC322626          DOI: 10.1172/JCI106364

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone.

Authors:  H Orskov; H G Thomsen; H Yde
Journal:  Nature       Date:  1968-07-13       Impact factor: 49.962

2.  Endogenous insulin and growth hormone response in children with newly diagnosed diabetes mellitus.

Authors:  A Drash; J B Field; L Y Garces; F M Kenny; D Mintz; A M Vazquez
Journal:  Pediatr Res       Date:  1968-03       Impact factor: 3.756

3.  Continuous blood glucose analysis in ambulatory fed subjects. I. General methodology.

Authors:  G D Molnar; E Ackerman; J W Rosevear; L C Gatewood; K E Moxness
Journal:  Mayo Clin Proc       Date:  1968-12       Impact factor: 7.616

4.  Metabolic homeostasis in juvenile diabetes mellitus. I. Role of growth hormone.

Authors:  L Baker; A W Root; N Haque; R Kaye
Journal:  Metabolism       Date:  1969-02       Impact factor: 8.694

5.  The rôle of growth hormone in the mobilization of fuel for muscular exercise.

Authors:  W M Hunter; C C Fonseka; R Passmore
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1965-10

6.  Studies on fatty acid metabolism in diabetics during exercise. I. Plasma free fatty acid concentration in juvenile, newly diagnosed diabetics during exercise.

Authors:  S Carlström
Journal:  Acta Med Scand       Date:  1967-05

7.  Effect of various blood sampling procedures on serum levels of immunoreactive human growth hormone.

Authors:  G Copinschi; M Hartog; J M Earll; R J Havel
Journal:  Metabolism       Date:  1967-05       Impact factor: 8.694

8.  Colorimetric micro-determination of free fatty acids in plasma.

Authors:  S Laurell; G Tibbling
Journal:  Clin Chim Acta       Date:  1967-04       Impact factor: 3.786

9.  Notes on the glucose oxidase method.

Authors:  N J Christensen
Journal:  Scand J Clin Lab Invest       Date:  1967       Impact factor: 1.713

10.  Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose.

Authors:  G Boden; J S Soeldner; R E Gleason; A Marble
Journal:  J Clin Invest       Date:  1968-04       Impact factor: 14.808

View more
  39 in total

1.  Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: normalization by insulin-treatment.

Authors:  C E Mogensen; M J Andersen
Journal:  Diabetologia       Date:  1975-06       Impact factor: 10.122

2.  Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus.

Authors:  J Wahren; L Hagenfeldt; P Felig
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  Threshold increases in plasma growth hormone in relation to plasma catecholamine and blood lactate concentrations during progressive exercise in endurance-trained athletes.

Authors:  J Chwalbínska-Moneta; F Krysztofiak; A Ziemba; K Nazar; H Kaciuba-Uściłko
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

4.  Clinical and pharmacological characterization of anomalous metoclopramide-induced growth hormone secretion in insulin-dependent diabetes mellitus.

Authors:  F Caviezel; G Lepore; M L Maglio; M Croci; G Comi; L Morricone
Journal:  Acta Diabetol Lat       Date:  1989 Apr-Jun

5.  Inappropriate growth-hormone (GH) response to thyrotropin-releasing hormone (TRH) occurs infrequently in well-regulated diabetes mellitus.

Authors:  O Giampietro; M Ferdeghini; R Miccoli; G Gregori; G Penno; S Bertoli; R Navalesi
Journal:  Acta Diabetol Lat       Date:  1990 Apr-Jun

Review 6.  [Diabetic angiopathy].

Authors:  K Lundbaek
Journal:  Acta Diabetol Lat       Date:  1973 Mar-Apr

7.  Plasma growth hormone response to insulin-induced hypoglycemia in diabetes mellitus.

Authors:  M K Sinha; G P Malik; G K Rastogi
Journal:  Acta Diabetol Lat       Date:  1974 Mar-Apr

8.  Impaired growth hormone response to human pancreatic growth hormone releasing factor [GRF(1-44)] in type 2 (non-insulin-dependent) diabetes.

Authors:  N T Richards; S M Wood; N D Christofides; S C Bhuttacharji; S R Bloom
Journal:  Diabetologia       Date:  1984-11       Impact factor: 10.122

9.  Quantitative evaluation of somatotrophic cells (SC) in the adenohypophysis of normal and diabetic male Chinese hamsters.

Authors:  P Deslex; G L Rossi
Journal:  Diabetologia       Date:  1976-10       Impact factor: 10.122

10.  Effect of physiological elevation of plasma growth hormone levels on ketone body kinetics and lipolysis in normal and acutely insulin-deficient man.

Authors:  U Keller; H Schnell; J Girard; W Stauffacher
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.